The changing face of paediatrics in the English-speaking Caribbean

R H Gray1

  • 1Department of Obstetrics and Gynaecology and Child Health, University of the West Indies, Kingston, Jamaica, WI.

Insights

Childhood health in the Caribbean has shifted from infectious diseases to non-communicable conditions and injuries. Urgent investment is needed in perinatal care, adolescent health, and injury prevention to improve child survival rates.

Area of Science:

  • Pediatrics
  • Public Health
  • Caribbean Health

Background:

  • Childhood mortality and morbidity patterns in the English-speaking Caribbean have undergone a significant epidemiological transition over the last 40 years.
  • Previously dominant infectious diseases like gastroenteritis and malnutrition have been superseded by acute respiratory illnesses, perinatal conditions, and physical injuries as leading causes of child mortality and morbidity.
  • Despite a decline in infant mortality, primarily due to reduced post-neonatal deaths, a substantial portion of the population remains under 15 years old.

Purpose of the Study:

  • To analyze the changing patterns of childhood mortality and morbidity in the English-speaking Caribbean.
  • To identify emerging health challenges and recommend areas for focused intervention and resource allocation.
  • To highlight the need for sustained investment in regional health and educational services.

Main Methods:

  • The study is based on an analysis of epidemiological trends and health statistics over a 40-year period in the English-speaking Caribbean.
  • It synthesizes data on causes of death and illness among children, examining shifts in disease prevalence.
  • The analysis considers demographic changes, including population growth and age distribution.

Main Results:

  • Acute respiratory illness, physical injury, and perinatal conditions are now the primary causes of childhood death and illness, replacing infectious diseases.
  • There is a growing prominence of perinatal disorders, psychosocial issues, and chronic childhood conditions.
  • Protein energy malnutrition (PEM) and pulmonary tuberculosis have re-emerged in some areas, linked to adverse economic conditions.

Conclusions:

  • There is an urgent need to prioritize perinatal and adolescent health, childhood disability, injury prevention (accidental and non-accidental), sexual abuse, and human immunodeficiency virus (HIV) infection.
  • Continued support and expansion of immunization programs are essential.
  • Addressing these challenges requires significant, long-term financial and human resource investment in the region's health and education sectors.

Related Concept Videos

Primary Healthcare Services01:30

Primary Healthcare Services

Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...